Gemcitabine plus docetaxel for advanced or metastatic non-small cell lung cancer: Similar survival to cisplatin plus vinorelbine and less toxicity

Cancer Treatment Reviews

Volumn 31, Issue 7, 2005, Pages 571-576

  Solomon, Benjamin ^a   Bunn Jr , Paul A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; CREATININE; DOCETAXEL; GEMCITABINE; NAVELBINE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; ADVANCED CANCER; ANEMIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FATALITY; FEBRILE NEUTROPENIA; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; INTERSTITIAL LUNG DISEASE; LARGE CELL CARCINOMA; LUNG DISEASE; LUNG EDEMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MULTICENTER STUDY; NEUTROPENIA; RANDOMIZED CONTROLLED TRIAL; SEPTIC SHOCK; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 27744567478     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ctrv.2005.08.001     Document Type: Note

References (19)

1. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials Br Med J 311 1995 899-909
2. P.A. Bunn Jr. Chemotherapy for advanced non-small-cell lung cancer: Who, what, when, why? J Clin Oncol 20 2002 23S-33S
3. J.H. Schiller D. Harrington C.P. Belani et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer N Engl J Med 346 2002 92-98
4. K. Kelly J. Crowley P.A. Bunn Jr. et al. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer: A Southwest Oncology Group trial J Clin Oncol 19 2001 3210-3218
5. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology. J Clin Oncol 1997;15:2996-3018.
6. J.L. Pujol J.L. Breton R. Gervais et al. Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: A phase III study addressing the case for cisplatin Ann Oncol 16 2005 602-610
7. V. Georgoulias E. Papadakis A. Alexopoulos et al. Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial Lancet 357 2001 1478-1484
8. V. Georgoulias A. Ardavanis X. Tsiafaki et al. Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial J Clin Oncol 23 2005 2937-2945
9. P. Kosmidis N. Mylonakis C. Nicolaides et al. Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: A phase III randomized trial J Clin Oncol 20 2002 3578-3585
10. E.F. Smit J.P. van Meerbeeck P. Lianes et al. Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975 J Clin Oncol 21 2003 3909-3917
11. V. Alberola C. Camps M. Provencio et al. Cisplatin plus gemcitabine versus a cisplatin-based triplet versus nonplatinum sequential doublets in advanced non-small-cell lung cancer: A Spanish Lung Cancer Group phase III randomized trial J Clin Oncol 21 2003 3207-3213
12. E. Laack N. Dickgreber T. Muller et al. Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: From the German and Swiss Lung Cancer Study Group J Clin Oncol 22 2004 2348-2356
13. C. Gridelli C. Gallo F.A. Shepherd et al. Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group J Clin Oncol 21 2003 3025-3034
14. G.P. Stathopoulos M. Veslemes N. Georgatou et al. Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: A randomized phase III trial Ann Oncol 15 2004 1048-1055
15. J.P. Sculier J.J. Lafitte J. Lecomte et al. A three-arm phase III randomised trial comparing combinations of platinum derivatives, ifosfamide and/or gemcitabine in stage IV non-small-cell lung cancer Ann Oncol 13 2002 874-882
16. F.M. Wachters J.W. Van Putten H. Kramer et al. First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: A phase III trial Br J Cancer 89 2003 1192-1199
17. G. D'Addario M. Pintilie N.B. Leighl R. Feld T. Cerny F.A. Shepherd Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: A meta-analysis of the published literature J Clin Oncol 23 2005 2926-2936
18. R.P. Abratt A. Szczesna K. Mattson et al. Vinorelbine (NVB)-carboplatin (CBDCA) vs non-platinum doublets in inoperable non-small cell lung cancer (NSCLC) patients (pts)-final results of the Glob 2 phase III with patient benefit analysis Proc Am Soc Clin Oncol 14S 2004 A7016
19. D.G. Pfister D.H. Johnson C.G. Azzoli et al. American Society of Clinical Oncology Treatment of Unresectable Non-Small-Cell Lung Cancer Guideline: Update 2003 J Clin Oncol 22 2004 330-353